Actinium Presents Preclinical Data at SITC Demonstrating Act

Actinium Presents Preclinical Data at SITC Demonstrating Actimab-A's Potential to Restore T Cell Immunity in the Solid Tumor Microenvironment Supporting Immunotherapy Combinations

/PRNewswire/ -- Actinium Pharmaceuticals, Inc. (NYSE AMERICAN: ATNM) (Actinium or the Company), a leader in the development of targeted radiotherapies, today...

Related Keywords

Sandesh Seth , Astellas Pharma , Exchange Commission , Oncology Lg Chem Life Sciences , Actimaba National Cancer Institute , Prnewswire Actinium Pharmaceuticals Inc , Society Of Immunotherapy Cancer , Annual Meeting , National Cancer Institute , Life Sciences , Actinium Pharmaceuticals , Nc ,